Valneva SE (VALN) — Earnings Call Analysis & IR Page

Valneva SE is a Healthcare company operating in Biotechnology with a $544.3M market cap.

Most recent earnings call: Q1 FY26 on May 13, 2026.

15 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

Confidence: 0.72

valneva.com/investors

Extracted from Unknown source, 2026-10-04.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 15 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for VALN.

$ curl https://api.spokenalpha.com/v1/companies/VALN

Get an API key API docs

FAQ

Frequently asked about VALN

Where can I find Valneva SE's (VALN) earnings call transcripts?

Spoken Alpha indexes VALN's earnings call transcripts at https://spokenalpha.com/companies/VALN. Each call links to attributed speakers and parsed analyst Q&A. Valneva SE's own investor relations page is at https://valneva.com/investors/.

When was Valneva SE's most recent earnings call?

Valneva SE (VALN) held its most recent earnings call on 2026-05-13, covering fiscal Q1 2026.

What sector is VALN in?

Valneva SE (VALN) operates in the Healthcare sector (Biotechnology industry).

Overview